Latvia

Reimbursed Care Access

Most classic psychedelics (psilocybin, MDMA, DMT, 5‑MeO‑DMT, ibogaine, ayahuasca, mescaline, 2C‑X) are controlled in Latvia with no authorized medical use outside approved research. Esketamine (Spravato) is authorized at the EU level and is listed in Latvian controlled‑substance regulations allowing supervised medical use; access in practice is delivered through medical channels and is typically private/out‑of‑pocket. Ketamine is a controlled medicine used in clinical settings (including anaesthesia) and is prescribed off‑label in some clinics for psychiatric indications, generally without routine public reimbursement.